APMA News - March 2012 - (Page 71)
EDITOR’S NOTE: The following is promotional information furnished by the company featured.
Corporate Profile: Advanced BioHealing
APMA’s newest corporate partner is Advanced BioHealing (ABH), a Shire company. ABH began its support of APMA in 2008 as a grant supporter of the Annual Scientific Meeting (The National) at the gold level. Since then, it has supported many educational programs and increased its support in 2012 to become an APMA Corporate Partner during APMA’s 100th Anniversary year. ABH specializes in development and commercialization of regenerative medicine therapies. ABH currently manufactures and markets Dermagraft, an active living cell product that is indicated for the treatment of diabetic foot ulcers (DFUs)—a serious complication of diabetes. Dermagraft is made from human fibroblast cells, which secrete human dermal collagen, matrix proteins, and growth factors, resulting in shorter healing times and fewer complications in treating DFUs compared to conventional care. In a pivotal trial, Dermagraft increased the proportion of DFUs that heal at 12 weeks by 64 percent compared to conventional therapy. During a critical time when diabetes prevalence is expected to increase dramatically and the risk for DFUs is growing steadily, ABH is dedicated to educating physicians and patients about the severity of DFUs and the importance of employing advanced wound care modalities, when appropriate, to heal chronic wounds. n
Oliver Foster, DPM, and Michael Davis to be Inducted into PM Podiatry Hall of Fame
Podiatry Management magazine (PM) has announced that Oliver Foster, DPM, and Michael Davis, executive director of the Pennsylvania Podiatric Medical Association, have been elected to receive the 2012 PM Lifetime Achievement Awards and will be inducted into the PM Podiatry Hall of Fame. Dr. Foster is the 29th podiatrist to receive this honor. Davis is the sixth non-podiatrist to be inducted into the Podiatry Hall of Fame. The awards ceremony will take place at a special luncheon on Thursday, August 16, 2012, as part of the APMA Annual Scientific Meeting (The National) in Washington, DC. Individual tickets are $60, or $600 for a table of 10. You can register for the luncheon when you register for The National or by using the registration form on page 54. Tickets also can be purchased and picked up in the registration area. All proceeds from ticket sales will benefit the APMA Educational Foundation Student Scholarship Fund. This year’s event is sponsored by Bako Podiatric Pathology Services and the Tetra Corporation, makers of Formula 3 Antifungal. This is a unique award in that recipients are not selected by a committee, but by the results of American podiatrists’ votes. Votes are cast by those completing PM’s annual survey, which appears in the August issue of the magazine. If you have any questions or would like to donate a ticket to the American Podiatric Medical Students’ Association so our students may attend this event, contact Sandra F. Arez, foundation coordinator, at 800-ASK-APMA, ext. 244, or by e-mail at firstname.lastname@example.org. n
Last year’s Podiatry Hall of Fame luncheon in Boston. APMA News March 2012
If you would like to try to load the digital publication without using Flash Player detection, please click here.